Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19

Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19

Individuals with chronic myeloid leukemia (CML) constitute a unique group within individuals with oncohematological disease (OHD). They receive treatment with tyrosine kinase inhibitors (TKIs) that present immunomodulatory properties, and they may eventually be candidates for treatment discontinuati...

Full description

Bibliographic Details
Main Authors: Sara Rodríguez-Mora, Magdalena Corona, Miriam Solera Sainero, Elena Mateos, Montserrat Torres, Clara Sánchez-Menéndez, Guiomar Casado-Fernández, Javier García-Pérez, Mayte Pérez-Olmeda, María Aranzazu Murciano-Antón, Javier López-Jiménez, Mayte Coiras, Valentín García-Gutiérrez
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
humoral immune response
cellular immune response
chronic myeloid 24 leukemia
COVID-19 vaccination
SARS-CoV-2
oncohematological disease
Online Access:https://www.mdpi.com/2072-6694/15/20/5066

Similar Items

Similar Items